Skip to main content
. 2023 Feb 1;62(18):2643–2650. doi: 10.2169/internalmedicine.0871-22

Table 2.

Between-group Comparison of Measurements.

Variables Allo-HSCT Auto-HSCT p
Mean (SD)
Accelerometer wear time, min/day 903.2±79.5 870.8±97.7 0.254
MVPA, min/day 40.4 (32.8) 34.9 (26.5) 0.768
Sedentary behavior, min/day 539.1 (106.9) 526.7 (123.0) 0.739
Handgrip, kg 29.7 (9.5) 33.0 (8.9) 0.262
Knee extension force, kgf/kgw 0.53 (0.16) 0.58 (0.18) 0.460
6MWT, m 481.7 (60.7) 457.9 (73.4) 0.270
HADS
Anxiety 3.2 (2.9) 3.9 (3.6) 0.521
Depression 4.3 (3.0) 5 (2.2) 0.264
EORTC QLQ C-30
Global health status 78.9 (15.7) 69.1 (20.3) 0.208
Physical function 87.8 (14.5) 86.2 (12.5) 0.473
Role function 88.5 (22.4) 88.5 (17.7) 0.798
Emotional function 90.6 (13.1) 90.6 (11.4) 0.718
Cognitive function 82.9 (19.7) 85.8 (8.9) 0.838
Social function 87.2 (24.1) 89.7 (19.2) 0.977
Fatigue 27.7 (19.7) 27.8 (21.3) 0.898
Nausea/vomiting 2.8 (7.4) 0 0.161
Pain 15.3 (20.1) 16.6 (27.7) 0.738
Dyspnea 7.4 (19.4) 20.4 (20.8) 0.011*
Insomnia 14.7 (21.3) 10.2 (15.2) 0.571
Appetite loss 12.0 (19.5) 12.8±20.8 0.955
Constipation 10.1 (17.2) 23±30.3 0.164
Diarrhea 13.8 (21.2) 10.2±15.2 0.692
Financial difficulties 19.4 (31.8) 12.7±16.1 0.936

MVPA: moderate-to-vigorous intensity physical activity, 6MWT: six minutes walking test, HADS: Hospital Anxiety and Depression Scale, EORTC QLQ C-30: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30

*p<0.05